OBJECTIVE: To determine serum level of slL-2 receptor in patients with vitiligo in a population in Al Ain, UAE. DESIGN: This is a prospective, descriptive, hospital based study. SETTING: Al Ain Medical District, Al Ain Hospital, UAE. SUBJECTS: Vitiligo patients seen at Al Ain hospital in 2003. RESULTS: The study was based on 32 patients. The sample consisted 21 males and 11 females. 15 healthy individuals were selected as control group. Serum level of slL-2R were significantly higher in vitiligo patient (112 +/- 129.2) than in healthy control (61.1 +/- 44.3 Pmol/L) P < 0.0001. Patient with short duration of the disease shows higher the serum level slL-2R. CONCLUSION: slL-2R showed significant difference between vitiligo patients and control.
OBJECTIVE: To determine serum level of slL-2 receptor in patients with vitiligo in a population in Al Ain, UAE. DESIGN: This is a prospective, descriptive, hospital based study. SETTING: Al Ain Medical District, Al Ain Hospital, UAE. SUBJECTS: Vitiligo patients seen at Al Ain hospital in 2003. RESULTS: The study was based on 32 patients. The sample consisted 21 males and 11 females. 15 healthy individuals were selected as control group. Serum level of slL-2R were significantly higher in vitiligo patient (112 +/- 129.2) than in healthy control (61.1 +/- 44.3 Pmol/L) P < 0.0001. Patient with short duration of the disease shows higher the serum level slL-2R. CONCLUSION: slL-2R showed significant difference between vitiligo patients and control.